PROGNOSTIC FACTORS OF VISION IN PATIENTS WITH RETINAL VEIN THROMBOSIS AFTER INTRAVITREAL INJECTION
Kazimova L.A.
DOI: 10.61775/2413-3302.v2i32.06
ABSTRACT
The correlation of visual acuity, reduced as a result of the formation of macular edema after retinal vein thrombosis,
and partially restored after injection treatment is presented in the article. A special method was applied for the study
of the violation of the integrity of the external limiting membrane (ELM) on the images of optical coherence tomography
(OCT). One-factor and multivariate linear regression analysis was conducted to assess the relationship between
visual acuity before and after treatment. It was shown that after treatment, the integrity of the ELM is an independent
and important factor in predicting visual acuity. When evaluating visual function in patients with macular edema
of the RVT following ranibizumab injections, the integrity of the ELM, especially below the center of the fovea, may
be more useful than other factors.
Keywords: integrity of the external limiting membrane, ranibizumab, retinal vein thrombosis, visual acuity, OCT
REFERENCES
- Huang P, Song Z, Sun X. Predictors of anti-vascular endothelial growth factor treatment
responses in macular edema following central vein occlusion // Chin Med J (Engl)
2014;127:3019-3023.
- Huang P, Niu W, Ni Z, Wang R, Sun X. A meta-analysis of anti-vascular endothelial
growth factor remedy for macular edema secondary to central retinal vein occlusion //
PLoS One. 2013;8:e82454. doi: 10.1371/journal.pone.0082454.
- McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen
HP, Wong TY. Natural history of central retinal vein occlusion: An evidence-based
systematic review // Ophthalmology. 2010;117:1113-1123. doi:
10.1016/j.ophtha.2010.01.060.
- Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, Nguyen HP, Wang
JJ, Wong TY. Natural history of branch retinal vein occlusion: An evidence-based
systematic review // Ophthalm., 2010;117:1094-1101. doi:10.1016/j.ophtha.2010.01. 058.
- Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H,
Wong TY. International eye disease consortium: The prevalence of retinal vein occlusion:
Pooled data from population studies from the United States, Europe, Asia and Australia //
Ophthalmology. 2010;117:313-319. doi: 10.1016/j.ophtha.2009.07.017.
- Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an
intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein
occlusion // Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
- Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG,
Murahashi WY, Cruise Investigators Ranibizumab for macular edema following central
retinal vein occlusion: Six-month primary end point results of a phase III study //
Ophthalmology. 2010;117:1124-1133. doi: 10.1016/j.ophtha.2010.02.022.
- Demir M, Oba E, Gulkilik G, Odabasi M, Ozdal E. Intravitreal bevacizumab for macular
edema due to branch retinal vein occlusion: 12-month results // Clin Ophthalmol.
2011;5:745-749. doi: 10.2147/OPTH.S19279.
- Figueroa MS, Contreras I, Noval S, Arruabarrena C. Results of bevacizumab as the
primary treatment for retinal vein occlusions // Br J Ophthalmol. 2010;94:1052-1056. doi:
10.1136/bjo.2009.173732.
- Gallego-Pinazo R, Dolz-Marco R, Pardo-Lopez D, Martinez-Castillo S, Lleo-Perez A,
Arevalo JF, Diaz-Llopis M. Ranibizumab for serous macular detachment in branch retinal
vein occlusions // Graefes Arch Clin Exp Ophthalmol. 2013;251:9-14. doi:
10.1007/s00417-012-2023-7.
- Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, Polak K,
Schmidt-Erfurth U. Intravitreal bevacizumab (Avastin) for macular oedema secondary to
retinal vein occlusion: 12-month results of a prospective clinical trial // Br J Ophthalmol.
2009;93:452-456. doi: 10.1136/bjo.2008.141085.
- Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB,
Klein R. Prospective study of intravitreal ranibizumab as a treatment for decreased visual
acuity secondary to central retinal vein occlusion // Am J Ophthalmol. 2009;147:298-306.
doi: 10.1016/j.ajo.2008.08.016.
- Gregori NZ, Rattan GH, Rosenfeld PJ, Puliafito CA, Feuer W, Flynn HW, Jr, Berrocal
AM, Al-Attar L, Dubovy S, Smiddy WE, et al. Safety and efficacy of intravitreal
bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion //
Retina. 2009;29:913-925. doi: 10.1097/IAE.0b013e3181aa8dfe.
- Boyd SR, Zachary I, Chakravarthy U, Allen GJ, Wisdom GB, Cree IA, Martin JF, Hykin
PG. Correlation of increased vascular endothelial growth factor with neovascularization
and permeability in ischemic central vein occlusion // Arch Ophthalmol.
2002;120:1644-1650. doi: 10.1001/archopht.120.12.1644.
- Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio
RG. Sustained benefits from ranibizumab for macular edema following central retinal vein
occlusion: Twelve-month outcomes of a phase III study // Ophthalmology.
2011;118:2041-2049. doi: 10.1016/j.ophtha.2011.02.038.
- Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio
RG, BRAVO Investigators Ranibizumab for macular edema following branch retinal vein
occlusion: Six-month primary end point results of a phase III study // Ophthalmology.
2010;117:1102-1112. doi: 10.1016/j.ophtha.2010.02.021.
- Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS, Marcus DM,
Feiner L, Patel A, RETAIN Study Group Long-term outcomes in patients with retinal vein
occlusion treated with ranibizumab: The RETAIN study // Ophthalmology.
2014;121:209-219. doi: 10.1016/j.ophtha.2013.08.038.
- Glanville J, Patterson J, McCool R, Ferreira A, Gairy K, Pearce I. Efficacy and safety of
widely used treatments for macular oedema secondary to retinal vein occlusion: A
systematic review // BMC Ophthalmol. 2014;14:7. doi: 10.1186/1471-2415-14-7.
- Kinge B, Stordahl PB, Forsaa V, Fossen K, Haugstad M, Helgesen OH, Seland J, Stene-
Johansen I. Efficacy of ranibizumab in patients with macular edema secondary to central
retinal vein occlusion: Results from the sham-controlled ROCC study // Am J Ophthalmol.
2010;150:310-314. doi: 10.1016/j.ajo.2010.03.028.
- Regnier SA, Larsen M, Bezlyak V, Allen F. Comparative efficacy and safety of approved
treatments for macular oedema secondary to branch retinal vein occlusion: A network
meta-analysis // BMJ Open. 2015;5:e007527. doi: 10.1136/bmjopen-2014-007527.
- Thom HH, Capkun G, Nixon RM, Ferreira A. Indirect comparisons of ranibizumab and
dexamethasone in macular oedema secondary to retinal vein occlusion // BMC Med Res
Methodol. 2014;14:140. doi: 10.1186/1471-2288-14-140.
- Wolf-Schnurrbusch UE, Ghanem R, Rothenbuehler SP, Enzmann V, Framme C, Wolf S.
Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to
central retinal vein occlusion // Invest Ophthalmol Vis Sci. 2011;52:3334-3337. doi:
10.1167/iovs.10-6097.
- Keane PA, Sadda SR. Predicting visual outcomes for macular disease using optical
coherence tomography // Saudi J Ophthalmol. 2011;25:145-158. doi: 10.1016/j.sjopt.2011.
01.003.
- Ota M, Tsujikawa A, Murakami T, Kita M, Miyamoto K, Sakamoto A, Yamaike N,
Yoshimura N. Association between integrity of foveal photoreceptor layer and visual
acuity in branch retinal vein occlusion // Br J Ophthalmol. 2007;91:1644-1649. doi:
10.1136/bjo. 2007.118497.
- Shin HJ, Chung H, Kim HC. Association between integrity of foveal photoreceptor layer
and visual outcome in retinal vein occlusion // Acta Ophthalmol. 2011;89:e35-e40. doi:
10.1111/j.1755-3768.2010.02063.x.
- Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H,
Meyer CH. Retinal vein occlusion study group: Predictive factors for functional
improvement after intravitreal bevacizumab therapy for macular edema due to branch
retinal vein occlusion // Graefes Arch Clin Exp Ophthalmol. 2011;249:183-192. doi:
10.1007/ s00417-010-1470-2.
- Bhisitkul RB, Campochiaro PA, Shapiro H, Rubio RG. Predictive value in retinal vein
occlusions of early versus late or incomplete ranibizumab response defined by optical
coherence tomography // Ophthalmology. 2013;120:1057-1063. doi: 10.1016/ j.ophtha.
2012.11.011.
- Sakamoto A, Tsujikawa A, Ota M, Yamaike N, Kotera Y, Miyamoto K, Kita M,
Yoshimura N. Evaluation of potential visual acuity in eyes with macular oedema
secondary to retinal vein occlusion // Clin Experiment Ophthalmol. 2009;37:208-216. doi:
10.1111/j.1442-9071.2009.01914.x.
- Clarkson JG, Chuang E, Gass D, Pedroso M, Cubillas T, Duria ES, Hess DJ, Rams I, Ball
M, Gutierrez A, et al. Evaluation of grid pattern photocoagulation for macular edema in
central vein occlusion. The central vein occlusion study group M report // Ophthalmology.
1995;102:1425-1433. doi: 10.1016/S0161-6420(95)30849-4.
- Battaglia Parodi M, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal
vein occlusion // Graefes Arch Clin Exp Ophthalmol. 1999;237:1024-1027. doi: 10.1007/
s004170050339.
- Ip MS, Scott IU, Van Veldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ,
Tolentino M, Chan CK, Gonzalez VH. A randomized trial comparing the efficacy and
safety of intravitreal triamcinolone with observation to treat vision loss associated with
macular edema secondary to central retinal vein occlusion: The standard care vs
corticosteroid for retinal vein occlusion (SCORE) study report 5 // Arch Ophthalmol.
2009;127:1101-1114. doi: 10.1001/archophthalmol. 2009.234.
- Zhao L, Li B, Feng K, Han L, Ma Z, Liu Y. Bevacizumab treatment for acute branch
retinal vein occlusion accompanied by subretinal hemorrhage // Curr Eye Res.
2015;40:752-756. doi: 10.3109/02713683.2014.952827.
- Ach T, Hoeh AE, Schaal KB, Scheuerle AF, Dithmar S. Predictive factors for changes in
macular edema in intravitreal bevacizumab therapy of retinal vein occlusion // Graefes
Arch Clin Exp Ophthalmol. 2010;248:155-159. doi: 10.1007/s00417-009-1167-6.
- Hoeh AE, Ruppenstein M, Ach T, Dithmar S. OCT patterns of macular edema and
response to bevacizumab therapy in retinal vein occlusion // Graefes Arch Clin Exp
Ophthalmol. 2010;248:1567-1572. doi: 10.1007/s00417-010-1419-5.
- Kang HM, Chung EJ, Kim YM, Koh HJ. Spectral-domain optical coherence tomography
(SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema
associated with branch retinal vein occlusion // Graefes Arch Clin Exp Ophthalmol.
2013;251:501-508. doi: 10.1007/s00417-012-2067-8.
- Oishi A, Hata M, Shimozono M, Mandai M, Nishida A, Kurimoto Y. The significance of
external limiting membrane status for visual acuity in age-related macular degeneration //
Am J Ophthalmol. 2010;150:27-32. doi: 10.1016/j. ajo.2010.02.012.
|